IdeS: A Bacterial Proteolytic Enzyme with Therapeutic Potential

Björn P. Johansson, Oonagh Shannon, Lars Björck · 2008

Read IdeS: A Bacterial Proteolytic Enzyme with Therapeutic Potential by Björn P. Johansson, Oonagh Shannon, Lars Björck (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001692.txt.

Description

Björn P. Johansson, Oonagh Shannon, and Lars Björck reviewed a bacterial enzyme with drug potential in a 2008 PLOS ONE research article. The enzyme is IdeS, made by Streptococcus pyogenes, a common cause of strep throat. IdeS cuts IgG antibodies with unusual precision, snipping one bond and disabling the antibody.

Harmful IgG antibodies drive several autoimmune diseases and can cause acute transplant rejection. An enzyme that removes them cleanly could become a treatment. The full text covers how IdeS works, its specificity, and the medical settings where it might help. Turning a bacterium's weapon against the immune system into a tool for calming that same system is the paper's central, elegant idea.

Catalog record

CREATORBjörn P. Johansson, Oonagh Shannon, Lars Björck
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001692

Browse the full library · About the Tower of Babel